Tennessee House Bill HB0403

Tennessee 2023-2024 Regular Session

• Introduced: 1/24/23
• Refer: 2/1/23
• Refer: 3/28/23
• Refer: 4/4/23
• Refer: 4/10/23
• Refer: 4/18/23
• Chaptered: 5/24/23
• Passed: 5/24/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 33; Title 38; Title 39, Chapter 15, Part 4; Title 39, Chapter 17; Title 43, Chapter 27; Title 53; Title 67 and Title 68, Chapter 7, relative to cannabis.

Impact

The legislation imposes a 6% sales tax on hemp-derived cannabinoid products sold at retail, with proceeds allocated to regulatory efforts within the agriculture and revenue departments. By structuring these regulations, the bill seeks to mitigate potential public health risks associated with unregulated products while ensuring that revenue generated from this emerging market can support necessary regulatory frameworks. This financial aspect aims to enhance state revenue and facilitate the effective management of cannabinoid product sales.

Summary

House Bill 403 aims to amend various sections of the Tennessee Code Annotated to regulate the sale and distribution of products containing hemp-derived cannabinoids. This bill introduces stringent regulations regarding manufacturing, labeling, and distributing these products, ensuring both safety and compliance with state laws. It is designed to clarify the legal status of cannabinoids derived from hemp and establishes a defined framework for their commercial activity within the state, addressing public safety and economic interests simultaneously.

Sentiment

Overall sentiment surrounding HB 403 is mixed, with proponents emphasizing the importance of regulation for consumer safety and public health, especially in the context of increasing hemp and cannabinoid sales. However, some stakeholders express concern regarding the potential impact on small businesses, arguing that compliance with the stringent licensing and testing requirements could place undue burdens on smaller operators. The discussions on the bill reveal a broader debate on how best to regulate this new market while promoting responsible economic growth.

Contention

Key points of contention include the restrictions imposed on sales to individuals under 21 years of age and the rigorous testing requirements for products. Critics argue that these regulations might limit consumer access while proponents maintain that they are essential for preventing underage access and ensuring product safety. Furthermore, concerns about the feasibility of compliance for small manufacturers pose significant questions about the market dynamics in light of the new regulations.